Search PubMed⌕ Search

Biomedical subjects

M Irshad

Publications and source records attributed to M Irshad.

At least 73 records · Page 4Linked to original sources
PubMed1986

Cell-mediated immunity in amoebic liver abscess.

Cell-mediated immunity studies were carried out in 26 cases of amoebic liver abscess by the leucocyte migration inhibition test and in 23 cases by T-cell counting. The tests were repeated after treatment and clinical recovery in 20 and 18 cases respectively. In addition, the leucocyte migration inhibition test was performed on 20 normal healthy controls and 11 Entamoeba histolytica cyst passers, and T-cell counting was carried out on 18 normal healthy controls and nine E. histolytica passers. The results of the present study show a transient state of immunodepression which may help E. histolytica to evade the defence mechanism of the host, and thereby invade target cells and produce liver abscess. This immune response is reversed after treatment and clinical recovery.

Cell Migration Inhibition↗
PubMed1985

Hepatitis virus non-A, non-B: the cause of a major public health problem in India.

Serological studies of hepatitis viruses A and B were carried out on 362 patients with acute viral hepatitis, 130 with fulminant hepatitis, and 56 with subacute hepatitis, and on samples of serum from 230 subjects during epidemics of viral hepatitis. A diagnosis of non-A, non-B viral hepatitis was made when serological tests showed that anti-HAV IgM and anti-HBc IgM were absent. Hepatitis virus non-A, non-B was the causative agent responsible for 58% of cases with acute viral hepatitis, 58% with fulminant hepatitis, 87% with subacute hepatitis, and 66% with epidemic hepatitis. A considerable proportion of patients (6-32%) were infected with both hepatitis virus non-A, non-B and hepatitis virus B. Viral hepatitis non-A, non-B is probably transmitted by infection of drinking-water and is the principal cause of hepatitis in India.

Antigens, Viral↗
PubMed1981

Purification and properties of an alpha-amylase protein-inhibitor from Arachis hypogaea seeds.

A protein showing highly specific inhibitory activity towards hog pancreatic and human salivary alpha-amylases (1,4-alpha-D-glucan glucanohydrolase, EC 3.2.1.1), but not towards plant and bacterial alpha-amylases, has been purified 197-fold from an aqueous extract of peanut cotyledons using heat treatment, (NH4)2SO4 precipitation and ion-exchange chromatography on DEAE- and CM-cellulose. The purified inhibitor was homogeneous by polyacrylamide gel electrophoresis. Its molecular weight, as determined by Sephadex G-100 gel-filtration, and its electrophoretic mobility at pH 8 relative to bromophenol blue, were 25 000 and 0.14, respectively. The inhibitory activity was relatively resistant to thermal treatment and markedly increased when the inhibitor was preincubated with the enzyme before the addition of starch. Further, the inhibition was found to be pH-dependent and non-competitive in nature.

Amylases↗
PubMedDate not supplied

Anti-pre-S antibodies in different groups of patients with hepatitis B virus infection.

The anti-pre-S antibody in the samples of sera from normal healthy persons and patients with different clinical types of liver diseases due to hepatitis B virus (HBV) infection was detected by a newly established enzyme-linked immunosorbent assay technique. This test is a blocking assay where anti-pre-S antibody in the patient's serum blocks subsequent addition of horse radish peroxidase-labelled polymerized human serum albumin (pHSA) to the pHSA-receptor site of HBsAg molecules fixed on a solid surface. Anti-pre-S activity was not detected in any from 95 healthy persons who were negative for all HBV-markers or from 105 healthy HBV carriers. In 12 sera from HBV vaccine recipients, anti-pre-S activity was noted in higher proportions compared with anti-HBs, after both the second and third doses of vaccine. Anti-pre-S activity was detected in small proportions of HBsAg positive sera from acute viral hepatitis (4.2%) and chronic active hepatitis (10%). In subacute viral hepatitis patients, the anti-pre-S antibody was totally absent. However, anti-pre-S activity was recorded in high proportions of HBsAg-positive sera from patients with cirrhosis of liver (57.2%) and fulminant hepatitis (41.6%). The anti-pre-S antibodies were assumed to be implicated in the clearance of HBV particles from circulation without causing tissue damage.

Enzyme-Linked Immunosorbent Assay↗